by Michael Parson | Jun 2, 2016 | Uncategorized
Genes and Drugs Patients differ in response to drugs. This variation can range from potentially life threatening adverse drug reactions to an equally serious lack of therapeutic efficacy even after taking the standard and safe dose of a drug. As knowledge of the human...
by Michael Parson | Mar 14, 2016 | Pharmacogenomics
Advancements in medical technology are occurring in the field of DNA testing. Technological advancements are making genomic testing faster and more cost-effective. Now these genotype tests can be done simply through a quick swab of a patient’s cheek and physicians can...
by Michael Parson | Jan 28, 2016 | Pharmacogenomics
Since 2007, when the FDA acknowledged that a blood-thinning drug’s effectiveness (or lack of) could be determined by how a person’s unique genetic structure responded to dosage, the medical field has been questioning its trial-by-error methodology....